Akebia Therapeutics
AKBA
$1.34
Share price
0.37%
Change (1 day)
47.80%
Change (1 year)
Categories
Operating Margin for Akebia Therapeutics (AKBA)
Operating Margin as of April 2024 (TTM): -20.79%
According to Akebia Therapeutics's latest financial reports and stock price the company's current Operating Margin is -20.79%. At the end of 2021 the company had an Operating Margin of -132.43%.
Operating Margin history for Akebia Therapeutics from 2017 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -132.43% | 1.99% |
| 2020 | -129.85% | 51.94% |
| 2019 | -85.46% | 3.26% |
| 2018 | -82.76% | 91.51% |
| 2017 | -43.21% | -99.51% |
| 2016 | -8,843.45% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | -210.05% | 🇺🇸 USA |
 Novartis NVS | 17.27% | -183.07% | 🇨🇭 Switzerland |
 Amgen AMGN | 34.59% | -266.38% | 🇺🇸 USA |
 Nektar Therapeutics
NKTR | -396.48% | 1,807.07% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.